Product
Hallux Terbinafine Subungual Gel
1 clinical trial
1 indication
Indication
Toenail OnychomycosisClinical trial
An Open Label Phase 2a Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Hallux Terbinafine Subungual Gel Administered to the Toenail Bed of Patients With Distal-Lateral Subungual OnychomycosisStatus: Active (not recruiting), Estimated PCD: 2024-09-30